Back
Repligen 10K Form
Sell
26
RGEN
Repligen
Last Price:
$139.98
Seasonality Move:
2.06%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | RGEN/Repligen Quarterly |
| 2023-10-31 | 10Q | RGEN/Repligen Quarterly |
| 2023-08-02 | 10Q | RGEN/Repligen Quarterly |
| 2023-05-02 | 10Q | RGEN/Repligen Quarterly |
| 2022-11-01 | 10Q | RGEN/Repligen Quarterly |
| 2022-08-02 | 10Q | RGEN/Repligen Quarterly |
Receive RGEN News And Ratings
See the #1 stock for the next 7 days that we like better than RGEN
RGEN Financial Statistics
Sales & Book Value
| Annual Sales: | $634.4M |
|---|---|
| Cash Flow: | $29.2M |
| Price / Cash Flow: | 55.27 |
| Annual Sales: | $35.17 |
| Price / Book: | 3.98 |
Profitability
| EPS (TTM): | -0.45000 |
|---|---|
| Net Income (TTM): | $-25.5M |
| Gross Margin: | $274.6M |
| Return on Equity: | -1.29% |
| Return on Assets: | -0.9% |
Repligen Earnings Forecast
Key Repligen Financial Ratios
-
The Gross Profit Margin over the past 40 years for RGEN is 43.29%.
-
The Selling, General & Administrative Expenses for RGEN have been equal to 41.51% of Gross Profit Margin.
-
The Research & Development expenses have been 6.81% of Revenue.
-
The Net Earning history of RGEN is -4.02% of Total Revenues.
-
Per Share Earnings over the last 40 years have been positive in 18 years.
Repligen Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Life Sciences Tools & Services |
| Sector: | Health Care |
| Current Symbol: | RGEN |
| CUSIP: | 759916 |
| Website: | repligen.com |
Debt
| Debt-to-Equity Ratio: | 0.27 |
|---|---|
| Current Ratio: | 8.41 |
| Quick Ratio: | 7.03 |
Price-to-Earnings
| Trailing P/E Ratio: | 258.21 |
|---|---|
| Forward P/E Ratio: | 64.23 |